Drugs@FDA document

SEROQUEL Review · NDA 020639 SUPPL-49

Drugs@FDA document · CHEPLAPHARM · Mar 7, 2012

Key facts

Drug name SEROQUEL
Document type Review
Application NDA020639
Submission SUPPL-49
Company CHEPLAPHARM
Document date Mar 7, 2012
FDA document accessdata.fda.gov

At a glance

  • Approval Letter Document categories
  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents